Introduction Patients
In clinical studies it is often necessary to perform venous punctures when large blood samples are required. This could be painful for the participants and may, particularly in children, lead to withdrawal from the study if the sampling is repeated. EMLA cream 5% produces superficial dermal analgesia. Several studies in hospitalized children have proved its efficacy in reducing pain in connection with the insertion of venous cannulas (Maunuksela & Korpela, 1986; Manner et al., 1987) or venepuncture (Kurien et al., 1985; Clarke & Radford, 1986 
Discussion
The cream was well tolerated by both the children and the teachers. Local reactions or itching were absent and school participation could be continued during the application time.
A previous study in adults indicated that there might be differences in the efficacy of EMLA cream, since the onset of action was delayed and the pain reduction lower in a group of Negro volunteers compared with Caucasians (Hymes & Spraker, 1986) . It is possible that the increased density and more compact nature of the stratum corneum in black skin might slow the absorption of a topically applied agent (Hymes & Spraker, 1986) . In the present study we therefore chose a longer application time of at least 120 min. The result with 93% pain-free venepunctures in this group of black children is at least equivalent to the results in white children after 60 min of application (Clarke & Radford, 1986; Maunuksela & Korpela, 1986) . The stratum corneum is thinner in children and it is possible that there are no ethnic differences in skin penetration in paediatric patients. Whether 60 min application time is generally sufficient in all children needs, however, to be investigated further.
